iBio Inc.

iBio Inc.
Stock Exchange NYSE
EPS
$1.06
Market Cap
$13.59 M
Shares Outstanding
19.7 M
Public Float
17.95 M

Profile

Address
600 Madison Avenue
New York New York 10022
United States
Employees -
Website http://www.ibioinc.com
Updated 07/08/2019
iBio, Inc. operates as a biotechnology company, which focuses on using its proprietary technologies and production facilities to provide product development and manufacturing services to clients, collaborators, and third-party customers as well as developing and commercializing its own product candidates. It operates through the iBio, Inc. and iBio CDMO business segments. The iBio CDMO segment is a subsidiary of the company, which develops and manufactures plant-made pharmaceuticals.

Financials

View All

Robert B. Kay
Executive Chairman & Chief Executive Officer
Seymour Flug
Independent Director